MicroRNAs: potential mediators and biomarkers of diabetic complications.
about
Circulating Biomarkers of Diabetic Retinopathy: An Overview Based on PhysiopathologyMicroRNAs Regulate Mitochondrial Function in Cerebral Ischemia-Reperfusion InjuryThe Role of MicroRNAs in Diabetic Complications-Special Emphasis on Wound HealingDiabetic retinopathy: variations in patient therapeutic outcomes and pharmacogenomicsExtracellular microRNAs and endothelial hyperglycaemic memory: a therapeutic opportunity?Mini-review: emerging roles of microRNAs in the pathophysiology of renal diseasesAcute Rejection After Kidney Transplantation Associates With Circulating MicroRNAs and Vascular InjuryTransforming growth factor β1 (TGF-β1) enhances expression of profibrotic genes through a novel signaling cascade and microRNAs in renal mesangial cellsMicroRNAs and their applications in kidney diseasesMicroRNA-185 targets SOCS3 to inhibit beta-cell dysfunction in diabetes.Epigenetic mechanisms in diabetic complications and metabolic memory.Novel Therapies in Development for Diabetic Macular Edema.Recent developments in epigenetics of acute and chronic kidney diseases.Preserved DNA Damage Checkpoint Pathway Protects against Complications in Long-Standing Type 1 Diabetes.MicroRNAs in diabetic nephropathy: functions, biomarkers, and therapeutic targets.Comprehensive approach to diabetic nephropathy.Increased serum microRNAs are closely associated with the presence of microvascular complications in type 2 diabetes mellitus.Regulation of Vascular Smooth Muscle Cell Dysfunction Under Diabetic Conditions by miR-504Oscillating glucose induces microRNA-185 and impairs an efficient antioxidant response in human endothelial cells.Diabetic Nephropathy: Emerging Biomarkers for Risk Assessment.Modulation of hippocampal gene expression of microRNA-146a/microRNA-155-nuclear factor-kappa B inflammatory signaling by troxerutin in healthy and diabetic rats.MicroRNAs in the Neural Retina.Diabetic nephropathy--emerging epigenetic mechanisms.Application of microRNAs in diagnosis and treatment of cardiovascular disease.Skewed Epigenetics: An Alternative Therapeutic Option for Diabetes Complications.The role of pharmacogenetics and advances in gene therapy in the treatment of diabetic retinopathy.microRNA profiling in atherosclerosis, diabetes, and migraine.50 years forward: mechanisms of hyperglycaemia-driven diabetic complications.MicroRNA Biomarkers in Neurodegenerative Diseases and Emerging Nano-Sensors Technology.Epigenetics of kidney disease.Diabetes-induced oxidative stress mediates upregulation of RhoA/Rho kinase pathway and hypercontractility of gastric smooth muscle.MicroRNA-150: A potential regulator in pathogens infection and autoimmune diseases.miR‑433 protects pancreatic β cell growth in high‑glucose conditions.CONTRIBUTION OF MYO-INOSITOL OXYGENASE IN AGE: RAGE MEDIATED RENAL TUBULO-INTERSTITIAL INJURY IN THE CONTEXT OF DIABETIC NEPHROPATHY.Relationship of Circulating miRNAs with Insulin Sensitivity and Associated Metabolic Risk Factors in Humans.microRNA-181a downregulates deptor for TGFβ-induced glomerular mesangial cell hypertrophy and matrix protein expression.Long non-coding RNA XIST exerts oncogenic functions in pancreatic cancer via miR-34a-5p.Biomarkers of diabetic nephropathy: A 2017 update.Pro-apoptotic effects of microRNA-365 on retinal neurons by targeting IGF-1 in diabetic rats: an in vivo and in vitro study.miR302a-3p May Modulate Renal Epithelial-Mesenchymal Transition in Diabetic Kidney Disease by Targeting ZEB1.
P2860
Q26744760-91FCF2FD-4CBE-4C0C-A28C-26F91AA5B6EAQ26780451-A9FE0237-523D-4EE5-9596-6FB246EF9083Q26827627-9154EA41-EC1F-4B17-A14B-58B822ADBA79Q26998543-5E75E975-7E29-47AE-8D98-D3A7C2C051AFQ28079163-9061A9D9-C33E-4C61-ACD0-AEDEF37CAF2BQ28354033-51FEA702-35A5-4BDD-AB18-D83096259CE2Q33874015-E02F702B-21C0-4517-A2EB-994CA60432BAQ34355665-3043E327-84A6-4776-ACC9-0C13DD523392Q34696427-44E32D04-8B5F-45CA-8603-8DD6FF323A36Q35057752-C7CC0358-4569-4E3D-9324-A97A4FBD8DB9Q35071700-2D3315E7-EE28-4F77-9402-EABCA280EF02Q35751912-2807ADEF-215D-40C9-AF45-2D9BDEE28C3EQ35909055-D8E70FAE-8ACF-4269-8DB2-E39FEDDAE4B8Q36108353-6D3A0D75-23BB-4191-828E-C4D4D6918F70Q36166755-030ADFB1-97FB-492D-A409-25234D4D69DEQ36466019-6E788006-9F07-4EDB-8A07-DED494509C58Q36527551-1816FCCF-4FAD-41CB-A872-325B18354F8AQ36849525-0B5292D0-B69B-4C22-B6E2-FC6293937BA1Q36855706-CC1B1752-737A-4E85-8A23-E3BF618FEC75Q36926187-5C986889-C121-4040-B962-68FE706C3136Q37501976-00D1BACC-B4F8-40BA-88E2-75AF7A38D983Q37679588-4D185F55-C4D1-419E-9689-AAEB6D0BC395Q38227252-1D3D2064-C552-4330-8F17-53085DA9D593Q38264294-D3D82496-2F2C-45FA-B0E8-386594B1493DQ38524836-D265D993-DA98-4C68-BA27-05989B43DE96Q38710512-41BE7A4D-28F5-4D71-BF4C-A52BF1C9EC28Q38827929-91D2DC0D-8C7A-48D0-B4D7-308F87568C73Q39014705-6056C7DD-B3A5-46CF-B1A8-F933A76C4F13Q39103202-E5AEDF4B-38BB-494E-92DE-D7E94D7433C8Q39175636-E908D680-6F39-406E-AF42-EC2C4FCC0787Q40960321-7DB09502-0643-4335-8F9D-71A24EC30B76Q41044723-1B6C132C-796E-475C-ACC8-8E9B4C933EC5Q42546741-8D455F7E-D2D9-4857-9513-1461FD8CF168Q46303824-E0EB99B0-DE76-46BE-A7A5-1F5B1B8C1AFDQ47649105-022A3891-5C05-4D8A-92B9-548BFDB6ADC3Q49353844-5DE57DE3-5D0B-426D-BD64-6C0D534F073DQ49378570-1D1BD018-1F27-4E2F-A8C1-27F997A282FFQ49686004-FDA95C66-0768-4228-AA13-5A54237F9860Q50087904-C32013EA-06BF-47D2-87A0-7D692C3ECB97Q52755792-327B3213-2B22-4F45-8221-883686433051
P2860
MicroRNAs: potential mediators and biomarkers of diabetic complications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 12 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MicroRNAs: potential mediators and biomarkers of diabetic complications.
@en
MicroRNAs: potential mediators and biomarkers of diabetic complications.
@nl
type
label
MicroRNAs: potential mediators and biomarkers of diabetic complications.
@en
MicroRNAs: potential mediators and biomarkers of diabetic complications.
@nl
prefLabel
MicroRNAs: potential mediators and biomarkers of diabetic complications.
@en
MicroRNAs: potential mediators and biomarkers of diabetic complications.
@nl
P2860
P1476
MicroRNAs: potential mediators and biomarkers of diabetic complications
@en
P2093
Nancy E Castro
Rama Natarajan
P2860
P356
10.1016/J.FREERADBIOMED.2013.06.009
P50
P577
2013-06-12T00:00:00Z